Effect of Novel Laser Shoe Photobiomodulation on Neuropathic Pain and Plantar Pressure Profile in Type 2 Diabetes Mellitus with Peripheral Neuropathy

被引:1
作者
Maiya, G. Arun [1 ]
Jadhav, Radhika Aditya [1 ]
Yadav, K. Hrishikesh [2 ]
Hande, H. Manjunatha [3 ]
Hebbar, Harishchandra [4 ]
Mohan, Karthik [5 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Hlth Profess, Ctr Diabetic Foot Care & Res, Dept Physiotherapy, Manipal 576104, Karnataka, India
[2] Indian Inst Technol, Ctr Healthcare Entrepreneurship, Hyderabad, India
[3] Manipal Acad Higher Educ, Kasturba Med Coll, Comprehens Geriatr Clin, Manipal 576104, Karnataka, India
[4] Manipal Acad Higher Educ, Sch Informat Sci, Manipal 576104, Karnataka, India
[5] Technomed Elect, Dept Operat, Chennai, India
关键词
Low-level laser therapy; neuropathy; spatiotemporal gait parameters; diabetes; photobiomodulation; neuropathic pain; LEVEL;
D O I
10.2174/0115733998244000231106040749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Photobiomodulation (PBM) or Low-level laser is used to treat diabetic foot complications. The existing method of laser application to the foot did not cover the foot's entire area to improve the foot's microcirculation. Therefore, we have developed a cost-effective Special LASER Shoe device, focusing exclusively on the entire foot region to manage neuropathic pain and other symptoms in individuals with type 2 diabetes mellitus. Objective The main objective of the present study was to evaluate the effect of this newly developed special laser shoe PBM on neuropathic pain and plantar pressure profile in individuals with type 2 diabetes mellitus with neuropathy. Methods We included 60 participants with diabetic peripheral neuropathy of both genders and age more than 20 years. Participants were treated with PBM by a specially designed novel Laser Shoe. Outcomes were clinical variables like Vibration Perception Threshold (VPT), Visual Analogue Scale (VAS), Michigan neuropathy screening instrument A&B, Ankle-Brachial Index (ABI), and Static dynamic gait parameters. Results Participants were with an average age of 62, and the average duration of diabetes was 11 years. Analysis showed a significant difference in VPT, VAS, Michigan neuropathic screening inventory, and ankle-brachial index (P < 0.05). Conclusion We conclude that Novel laser shoe photobiomodulation using 'Laser Shoe' effectively reduces peripheral neuropathic pain. It is also effective in reducing average and maximum plantar pressure. Reduction in neuropathic pain and improvement in plantar pressure distribution can reduce further complications.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental Type 2 diabetes
    De Visser, Adriena
    Hemming, Amanda
    Yang, Christina
    Zaver, Shaila
    Dhaliwal, Raj
    Jawed, Zaid
    Toth, Cory
    NEUROBIOLOGY OF DISEASE, 2014, 62 : 18 - 30
  • [32] Novel Vibrating Foot Orthoses for Improving Tactile Sensation in Type 2 Diabetes With Peripheral Neuropathy
    Thimabut, Wachirayongyot
    Thimabut, Natapatchakrid
    Peng, Liang
    Hou, Zeng-Guang
    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2024, 32 : 2993 - 3005
  • [33] Decreased indirect bilirubin is associated with the prevalence of peripheral neuropathy in Chinese female patients with type 2 diabetes mellitus
    Wang, Guofeng
    Yan, Yongxin
    Xu, Ning
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 12621 - 12628
  • [34] Assessment of peripheral neuropathy using measurement of the current perception threshold with the Neurometer® in patients with type 2 diabetes mellitus
    Matsutomo, R
    Takebayashi, K
    Aso, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 (04) : 442 - 453
  • [35] Effect of silymarin on lipid profile and glycemic control in patients with type 2 diabetes mellitus
    Ferdowsi, Samira
    Shidfar, Farzad
    Heidari, Iraj
    Kashi, Maryam
    Sohouli, Mohammad Hassan
    Zadeh, Sara Sarrafi
    PHYTOTHERAPY RESEARCH, 2024, 38 (09) : 4667 - 4674
  • [36] The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes
    Jin, Y. -P.
    Su, X. -F.
    Li, H. -Q.
    Wu, J. -D.
    Ding, B.
    Sun, R.
    Shan, T.
    Ye, L.
    Ma, J. -H.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (10) : 618 - 621
  • [37] Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
    Dimitrios Baltzis
    Matthieu Roustit
    Maria G. Grammatikopoulou
    Dimitrios Katsaboukas
    Vassileios Athanasiou
    Ioannis Iakovou
    Aristidis Veves
    Christos Manes
    Maria-Christina Trakatelli
    Advances in Therapy, 2016, 33 : 1840 - 1847
  • [38] Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
    Baltzis, Dimitrios
    Roustit, Matthieu
    Grammatikopoulou, Maria G.
    Katsaboukas, Dimitrios
    Athanasiou, Vassileios
    Iakovou, Ioannis
    Veves, Aristidis
    Manes, Christos
    Trakatelli, Maria-Christina
    ADVANCES IN THERAPY, 2016, 33 (10) : 1840 - 1847
  • [39] Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients
    Skapare, Elina
    Konrade, Ilze
    Liepinsh, Edgars
    Strele, Ieva
    Makrecka, Marina
    Bierhaus, Angelika
    Lejnieks, Aivars
    Pirags, Valdis
    Dambrova, Maija
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (03) : 262 - 267
  • [40] Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus
    Guo, Kai
    Elzinga, Sarah
    Eid, Stephanie
    Figueroa-Romero, Claudia
    Hinder, Lucy M.
    Pacut, Crystal
    Feldman, Eva L.
    Hur, Junguk
    EPIGENETICS, 2019, 14 (08) : 766 - 779